Autodesk (ADSK) has been drifting sideways lately, with the stock roughly flat over the past month but down around 9% in the past 3 months, despite double digit annual revenue and earnings growth. See ...

It has been about a month since the last earnings report for Acadia Pharmaceuticals (ACAD). Shares have added about 22.6% in that time frame, outperforming the S&P 500. But investors have to be ...

Autodesk Inc. (NASDAQ: ADSK) is scheduled to report its third-quarter results on Tuesday. The company is likely to report its quarterly revenue and earnings slightly below consensus estimates but ...

Computer-aided design (CAD) is the go-to method for designing most of today's physical products. Engineers use CAD to turn 2D sketches into 3D models that they can then test and refine before sending ...

Autodesk delivered another quarter of outperformance, with revenue up 18% year over year. Operating margin expanded 20 basis points sequentially, reaching a new high of 25.4%, thanks to the ...

Autodesk’s (NASDAQ:ADSK) recent analyst day showcased a strategic pivot towards maximizing profitability and leveraging AI-driven monetization, signaling a forward-looking evolution of its business ...

Autodesk’s AI story has matured. While past Autodesk University events focused on promises and prototypes, this year Autodesk showcased live tools, giving customers a clear view of how AI could soon ...

At NACDS Total Store Expo, DSN spoke with Darin Gleason, U.S. chain and retail sales director for ScriptPro, to talk about the company’s distinctive approach to pharmacy technology Gleason spoke about ...

Autodesk has introduced neural CAD, a new category of 3D generative AI foundation models coming to Fusion and Forma, which the company says will “completely reimagine the traditional software engines ...

Autodesk will release artificial intelligence assistants based on a uniform platform that’s an AI “partner” across all platforms that will be able to interrogate design, ask questions and iterate ...